IL1B and myeloid sarcoma: Ramgolam et al. [31] showed that IFNβ downregulates IL-1β and IL-23p19 gene expression whereas it upregulates IL-12p35 and IL-27p28 in MS patients' dendritic cells, leading to suppression of Th17 differentiation.